T1	Participants 64 157	spinal anesthesia after prophylactic administration of intravenous fluids or vasoconstrictors
T2	Participants 402 421	Patients (n = 1066)
T3	Participants 201 285	arterial hypotension and/or bradycardia requiring treatment during spinal anesthesia
T4	Participants 641 737	All patients breathed O2-enriched air during spinal anesthesia (4 mL of plain 0.5% bupivacaine).
